Lasa Supergenerics (NSE:LASA) Equity-to-Asset: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LASA Lasa Supergenerics Ltd NSE:LASA
45 GF Score
Price ₹6.20
GF Value ₹1.21
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lasa Supergenerics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Lasa Supergenerics's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹ Mil. Lasa Supergenerics's Total Assets for the quarter that ended in Jun. 2026 was ₹ Mil.

The historical rank and industry rank for Lasa Supergenerics's Equity-to-Asset or its related term are showing as below:

NSE:LASA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33   Med: 0.7   Max: 0.83
Current: 0.75

During the past 10 years, the highest Equity to Asset Ratio of Lasa Supergenerics was 0.83. The lowest was 0.33. And the median was 0.70.

NSE:LASA's Equity-to-Asset is ranked better than
73.19% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs NSE:LASA: 0.75

Lasa Supergenerics  (NSE:LASA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Lasa Supergenerics Equity-to-Asset Related Terms


Lasa Supergenerics Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Lasa Supergenerics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lasa Supergenerics Equity-to-Asset Chart

Lasa Supergenerics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.72 0.64 0.83 0.75

Lasa Supergenerics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.78 - 0.75 -

NSE:LASA vs ZTS: Equity-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lasa Supergenerics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lasa Supergenerics Equity-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lasa Supergenerics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Lasa Supergenerics's Equity-to-Asset falls into.


NSE:LASA
45GF Score
Lasa Supergenerics Ltd NSE:LASA
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lasa Supergenerics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Lasa Supergenerics's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Equity to Asset (A: Mar. 2026 )=Total Stockholders Equity/Total Assets
=496.229/665.67
=0.75

Lasa Supergenerics's Equity to Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

Equity to Asset (Q: Jun. 2026 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Lasa Supergenerics (NSE:LASA) Overvalued in 2026?

Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued. The current stock price of ₹6.20 is trading 412.4% above its estimated GF Value™ of ₹1.21. GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.

Key valuation signals for NSE:LASA:

  • Equity-to-Asset:
  • GF Value™: ₹1.21 vs. price of ₹6.20 (412.4% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the NSE:LASA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lasa Supergenerics Business Description

Other Exchanges 540702:India
Address Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.
45GF Score

Get the complete analysis for NSE:LASA

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6.20
Price
₹1.21
GF Value